[1]
“Risk Assessment of QT-Prolonging Drug Combinations and Their Association with QTc Interval Prolongation Among Psychiatric Patients: A Prospective Observational Study”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/rveyrh87.